分子診断の世界市場：四半期データストリーム（2024年）

本レポートでは、世界の分子診断市場について調査し、市場の規模と成長に関する最新情報、世界の主要通貨の変動が各市場の実質成長率にどのような影響を及ぼしたかなどについてまとめています。

目次

四半期ごとの市場予測

• 分子感染症（呼吸器、肝炎、HIV、HAI/敗血症、STI、結核、その他の感染症）
• 分子腫瘍学（CDxおよび分子組織学を含む分子アッセイ）
• 分子遺伝学的検査（遺伝性疾患とNIPT）
• 分子移植
• 分子NAT血液バンク検査
• 分子POC検査
• 分子COVID検査

NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports.

The most up-to-date information for company-wide success.

Buyers will receive data updates after each financial quarter for one year (for a total of four updates ). These comprehensive updates come in an Excel spreadsheet report easily usable by your marketing, business development, product management teams, and company executives.

With this data on hand your company will always have the most up-to-date information on the size and growth of the molecular diagnostics market. Also included in each update is how fluctuations in major global currencies have affected real growth for each of the markets examined. Corporate leadership teams can use the Datastream as a guide to help determine quarterly market share, and to measure your company's growth against the industry as a whole.

Quarterly Market estimates include:

• Molecular Infectious Disease (Respiratory, Hepatitis, HIV, HAIs/Sepsis, STI, TB and Other Infections)
• Molecular Oncology (Molecular Assays including CDx and Molecular Histology)
• Molecular Genetic Testing (Inherited Diseases and NIPT)
• Molecular Transplantation
• Molecular NAT Blood Banking Tests
• Molecular Molecular Point of Care Tests
• Molecular COVID Testing